161 related articles for article (PubMed ID: 38104786)
1. Potential systemic effects of acquired CFTR dysfunction in COPD.
Miravitlles M; Criner GJ; Mall MA; Rowe SM; Vogelmeier CF; Hederer B; Schoenberger M; Altman P
Respir Med; 2024 Jan; 221():107499. PubMed ID: 38104786
[TBL] [Abstract][Full Text] [Related]
2. Cigarette Smoke-Induced Acquired Dysfunction of Cystic Fibrosis Transmembrane Conductance Regulator in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
Shi J; Li H; Yuan C; Luo M; Wei J; Liu X
Oxid Med Cell Longev; 2018; 2018():6567578. PubMed ID: 29849907
[TBL] [Abstract][Full Text] [Related]
3. Chronic obstructive pulmonary disease and the modulation of CFTR by acute exposure to cigarette smoke.
Hanrahan JW; Abu-Arish A; Wong FH; Turner MJ; Carlile GW; Thomas DY; Cantin AM
Am J Physiol Cell Physiol; 2022 Nov; 323(5):C1374-C1392. PubMed ID: 36121129
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial.
Rowe SM; Jones I; Dransfield MT; Haque N; Gleason S; Hayes KA; Kulmatycki K; Yates DP; Danahay H; Gosling M; Rowlands DJ; Grant SS
Int J Chron Obstruct Pulmon Dis; 2020; 15():2399-2409. PubMed ID: 33116455
[TBL] [Abstract][Full Text] [Related]
5. Impact of heterozygote CFTR mutations in COPD patients with chronic bronchitis.
Raju SV; Tate JH; Peacock SK; Fang P; Oster RA; Dransfield MT; Rowe SM
Respir Res; 2014 Feb; 15(1):18. PubMed ID: 24517344
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a novel CFTR potentiator in COPD ferrets with acquired CFTR dysfunction.
Kaza N; Lin VY; Stanford D; Hussain SS; Falk Libby E; Kim H; Borgonovi M; Conrath K; Mutyam V; Byzek SA; Tang LP; Trombley JE; Rasmussen L; Schoeb T; Leung HM; Tearney GJ; Raju SV; Rowe SM
Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34916262
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoke and CFTR: implications in the pathogenesis of COPD.
Rab A; Rowe SM; Raju SV; Bebok Z; Matalon S; Collawn JF
Am J Physiol Lung Cell Mol Physiol; 2013 Oct; 305(8):L530-41. PubMed ID: 23934925
[TBL] [Abstract][Full Text] [Related]
8. CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease.
Fernandez Fernandez E; De Santi C; De Rose V; Greene CM
Expert Rev Respir Med; 2018 Jun; 12(6):483-492. PubMed ID: 29750581
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond.
Mall MA; Criner GJ; Miravitlles M; Rowe SM; Vogelmeier CF; Rowlands DJ; Schoenberger M; Altman P
Eur Respir J; 2023 Apr; 61(4):. PubMed ID: 37003609
[TBL] [Abstract][Full Text] [Related]
10. Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance.
Raju SV; Solomon GM; Dransfield MT; Rowe SM
Clin Chest Med; 2016 Mar; 37(1):147-58. PubMed ID: 26857776
[TBL] [Abstract][Full Text] [Related]
11. Cystic Fibrosis Transmembrane Conductance Regulator. Implications in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Cantin AM
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S150-5. PubMed ID: 27115950
[TBL] [Abstract][Full Text] [Related]
12. Cystic Fibrosis Transmembrane Conductance Regulator: Roles in Chronic Obstructive Pulmonary Disease.
Dransfield M; Rowe S; Vogelmeier CF; Wedzicha J; Criner GJ; Han MK; Martinez FJ; Calverley P
Am J Respir Crit Care Med; 2022 Mar; 205(6):631-640. PubMed ID: 34982651
[TBL] [Abstract][Full Text] [Related]
13. Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial.
Martinez FJ; Criner GJ; Gessner C; Jandl M; Scherbovsky F; Shinkai M; Siler TM; Vogelmeier CF; Voves R; Wedzicha JA; Bartels C; Bottoli I; Byiers S; Cardenas P; Eckert JH; Gutzwiller FS; Knorr B; Kothari M; Parlikar R; Tanase AM; Franssen FME
Am J Respir Crit Care Med; 2023 Aug; 208(4):417-427. PubMed ID: 37411039
[No Abstract] [Full Text] [Related]
14.
Saferali A; Qiao D; Kim W; Raraigh K; Levy H; Diaz AA; Cutting GR; Cho MH; Hersh CP;
Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 34996830
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Grand DL; Gosling M; Baettig U; Bahra P; Bala K; Brocklehurst C; Budd E; Butler R; Cheung AK; Choudhury H; Collingwood SP; Cox B; Danahay H; Edwards L; Everatt B; Glaenzel U; Glotin AL; Groot-Kormelink P; Hall E; Hatto J; Howsham C; Hughes G; King A; Koehler J; Kulkarni S; Lightfoot M; Nicholls I; Page C; Pergl-Wilson G; Popa MO; Robinson R; Rowlands D; Sharp T; Spendiff M; Stanley E; Steward O; Taylor RJ; Tranter P; Wagner T; Watson H; Williams G; Wright P; Young A; Sandham DA
J Med Chem; 2021 Jun; 64(11):7241-7260. PubMed ID: 34028270
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function.
Bodas M; Silverberg D; Walworth K; Brucia K; Vij N
Antioxid Redox Signal; 2017 Sep; 27(7):433-451. PubMed ID: 28006950
[TBL] [Abstract][Full Text] [Related]
17. Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD.
Dransfield MT; Wilhelm AM; Flanagan B; Courville C; Tidwell SL; Raju SV; Gaggar A; Steele C; Tang LP; Liu B; Rowe SM
Chest; 2013 Aug; 144(2):498-506. PubMed ID: 23538783
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction.
Rasmussen JE; Sheridan JT; Polk W; Davies CM; Tarran R
J Biol Chem; 2014 Mar; 289(11):7671-81. PubMed ID: 24448802
[TBL] [Abstract][Full Text] [Related]
19. The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke.
Raju SV; Lin VY; Liu L; McNicholas CM; Karki S; Sloane PA; Tang L; Jackson PL; Wang W; Wilson L; Macon KJ; Mazur M; Kappes JC; DeLucas LJ; Barnes S; Kirk K; Tearney GJ; Rowe SM
Am J Respir Cell Mol Biol; 2017 Jan; 56(1):99-108. PubMed ID: 27585394
[TBL] [Abstract][Full Text] [Related]
20. Vaporized E-Cigarette Liquids Induce Ion Transport Dysfunction in Airway Epithelia.
Lin VY; Fain MD; Jackson PL; Berryhill TF; Wilson LS; Mazur M; Barnes SJ; Blalock JE; Raju SV; Rowe SM
Am J Respir Cell Mol Biol; 2019 Aug; 61(2):162-173. PubMed ID: 30576219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
